TCL Archive In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind January 23, 1976
TCL Archive “NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s September 20, 1991
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL June 11, 2014
TCL Archive Texas (Galveston) Scores Nine Points Ahead Of RPMI In Organ Systems Competitio; NCAB To Decide Award May 4, 1984
